Kbc Group Nv Biotechnology

Kbc Group Nv

$32.2 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
DNLI Denali Therapeutics Inc.	$1.97B	$88,000 0.0% of portfolio	6,450	Q1 2025 Added 1.83%
ACAD Acadia Pharmaceuticals Inc	$3.54B	$85,000 0.0% of portfolio	5,093	Q4 2024 Added 67.04%
APLS Apellis Pharmaceuticals, Inc.	$2.19B	$84,000 0.0% of portfolio	3,850	Q1 2025 Reduced 96.31%
ARQT Arcutis Biotherapeutics, Inc.	$957M	$84,000 0.0% of portfolio	5,368	Q1 2025 New
FOLD Amicus Therapeutics, Inc.	$1.75B	$83,000 0.0% of portfolio	10,154	Q4 2024 Added 44.36%
BEAM Beam Therapeutics Inc.	$1.44B	$81,000 0.0% of portfolio	4,143	Q4 2024 Added 103.19%
AGIO Agios Pharmaceuticals, Inc.	$2.15B	$77,000 0.0% of portfolio	2,615	Q4 2024 Added 30.49%
BCRX Biocryst Pharmaceuticals Inc	$1.67B	$76,000 0.0% of portfolio	10,198	Q4 2024 Added 80.14%
TVTX Travere Therapeutics, Inc.	$1.09B	$75,000 0.0% of portfolio	4,187	Q1 2025 New
INVA Innoviva, Inc.	$1.36B	$74,000 0.0% of portfolio	4,100	Q4 2024 Added 73.95%
MNKD Mannkind Corp	$1.04B	$72,000 0.0% of portfolio	14,348	Q1 2025 New
IDYA Ideaya Biosciences, Inc.	$1.02B	$69,000 0.0% of portfolio	4,197	Q4 2024 Added 84.56%
CLDX Celldex Therapeutics, Inc.	$1.09B	$68,000 0.0% of portfolio	3,728	Q4 2024 Added 79.14%
KYMR Kymera Therapeutics, Inc.	$2.46B	$68,000 0.0% of portfolio	2,479	Q1 2025 Added 15.25%
ARDX Ardelyx, Inc.	$693M	$67,000 0.0% of portfolio	13,706	Q4 2024 Added 101.83%
JANX Janux Therapeutics, Inc.	$998M	$66,000 0.0% of portfolio	2,461	Q1 2025 New
RXRX Recursion Pharmaceuticals, Inc.	$953M	$65,000 0.0% of portfolio	12,307	Q4 2024 Added 61.89%
ASND Ascendis Pharma A/S	$9.76B	$64,000 0.0% of portfolio	411	Q3 2024 New
SNDX Syndax Pharmaceuticals Inc	$557M	$64,000 0.0% of portfolio	5,180	Q1 2025 Reduced 25.51%
ADPT Adaptive Biotechnologies Corp	$1.65B	$62,000 0.0% of portfolio	8,378	Q4 2024 New
HRMY Harmony Biosciences Holdings, Inc.	$2.05B	$61,000 0.0% of portfolio	1,844	Q4 2024 Added 79.9%
IMVT Immunovant, Inc.	$3.55B	$61,000 0.0% of portfolio	3,542	Q1 2025 Added 14.29%
VERA Vera Therapeutics, Inc.	$619M	$59,000 0.0% of portfolio	2,477	Q4 2024 Added 127.25%
NVAX Novavax Inc	$545M	$51,000 0.0% of portfolio	7,954	Q4 2024 Added 97.03%
XNCR Xencor Inc	$528M	$49,000 0.0% of portfolio	4,570	Q1 2025 Added 16.11%
WVE Wave Life Sciences Ltd.	$601M	$44,000 0.0% of portfolio	5,440	Q4 2024 New
NTLA Intellia Therapeutics, Inc.	$908M	$43,000 0.0% of portfolio	6,093	Q4 2024 Added 62.35%
IOVA Iovance Biotherapeutics, Inc.	$317M	$41,000 0.0% of portfolio	12,303	Q4 2024 Added 105.67%
GERN Geron Corp	$518M	$39,000 0.0% of portfolio	24,414	Q4 2024 Added 45.13%
VIR Vir Biotechnology, Inc.	$730M	$39,000 0.0% of portfolio	5,958	Q1 2025 Reduced 33.58%
RCKT Rocket Pharmaceuticals, Inc.	$231M	$37,000 0.0% of portfolio	5,475	Q4 2024 Added 159.6%
DYN Dyne Therapeutics, Inc.	$423M	$33,000 0.0% of portfolio	3,135	Q4 2024 Added 45.34%
ARVN Arvinas, Inc.	$419M	$20,000 0.0% of portfolio	2,885	Q4 2024 Added 76.99%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.